What are the facts?
In 2000, Credit Suisse First Boston (CSFB) agreed to acquire Donaldson, Lufkin & Jenrette, Inc. (DLJ) in a cash merger. After DLJ's stockholders approved the transaction, the closing did not occur immediately; instead, the defendants allegedly delayed the closing beyond the earliest possible date when all material conditions could have been satisfied. Former DLJ stockholders brought suit alleging that DLJ's directors breached their fiduciary duties by agreeing to or causing an unnecessary delay that benefited CSFB (which held the cash consideration and thus captured the time value/interest on those funds) and harmed DLJ's stockholders, who were deprived of the timely receipt of their merger consideration. The plaintiffs sought damages measured by the lost time value of the merger consideration for the period of the delay. The Court of Chancery dismissed the complaint as asserting derivative claims and for failure to make demand or plead demand futility. Plaintiffs appealed, arguing their claims were direct because the harm and remedy ran to the stockholders personally.
What is the legal issue?
Are claims alleging that directors wrongfully delayed the closing of a cash-out merger—thereby depriving stockholders of the time value of their merger consideration—direct claims belonging to the stockholders or derivative claims belonging to the corporation?
What rule applies?
To determine whether a stockholder claim is direct or derivative, courts must answer two questions: (1) who suffered the alleged harm—the corporation or the stockholders, individually; and (2) who would receive the benefit of any recovery or other remedy—the corporation or the stockholders, individually. The prior "special injury" formulation and focus on whether the duty was owed directly to stockholders are not controlling; the analysis centers on the nature of the alleged harm and to whom the remedy flows.
What did the court hold?
The claims are direct. The alleged harm—the loss of the time value of the stockholders' merger consideration due to an unnecessary closing delay—was suffered by the stockholders individually, and any recovery would flow directly to them, not to the corporation. The Court reversed the Court of Chancery's dismissal and remanded for further proceedings.
What is the reasoning?
The Delaware Supreme Court rejected the "special injury" approach as confusing and unhelpful, emphasizing that the correct inquiry focuses on the nature of the harm and the beneficiary of the remedy. Here, the plaintiffs did not allege an injury to DLJ as a corporate entity. The corporation had no entitlement to the merger consideration; that right belonged solely to the stockholders whose shares were to be converted into the right to receive cash. Thus, the economic injury from any wrongful delay—lost interest or time value on that cash—was suffered by the stockholders themselves. Likewise, any monetary recovery would appropriately be paid to those stockholders, not to DLJ. By centering the analysis on "who was harmed" and "who benefits from the remedy," the Court clarified that even harms shared pro rata among all stockholders can be direct if the corporation itself suffered no injury. The Court expressly disapproved reliance on whether the alleged duty was owed "to the corporation" or "to stockholders" as the primary determinant, warning that such labels obscure the real question. Applying its new test, the Court concluded that the complaint stated direct claims and therefore should not have been dismissed for failure to satisfy derivative demand requirements.
Why is this case significant?
Tooley is the leading Delaware authority for distinguishing direct and derivative stockholder claims. It replaced the amorphous "special injury" standard with a predictable two-prong test, profoundly affecting litigation strategy: labeling a claim as direct avoids Rule 23.1 demand requirements, affects who controls the suit (board or stockholders), determines the scope of discovery and remedies, and shapes settlement dynamics. The case is a building block for later jurisprudence, including the treatment of dilution and dual-nature claims, and it continues to guide Delaware and non-Delaware courts in corporate and securities disputes. For law students, mastering Tooley is essential to understanding shareholder standing, demand futility, and the architecture of fiduciary-duty litigation.
What is the Tooley test in plain terms?
Ask two questions: (1) Who took the hit—the corporation or the stockholders personally? and (2) Who would get the money or remedy if the plaintiffs win—the corporation or the stockholders? If the corporation took the hit and would get the recovery, the claim is derivative; if stockholders took the hit and would receive the recovery, the claim is direct.
Does a harm shared by all stockholders automatically make a claim derivative?
No. Tooley rejected the "special injury" concept. A claim can be direct even if every stockholder suffers the same harm pro rata, so long as the injury is to stockholders in their capacity as stockholders and not to the corporation. The delayed payment of merger consideration in Tooley is a classic example: every stockholder was harmed equally, yet the claim was direct.
Why does the direct-versus-derivative distinction matter procedurally?
It determines standing and pleading burdens. Derivative claims must satisfy Court of Chancery Rule 23.1, including either making a pre-suit demand on the board or pleading demand futility with particularity, and are subject to possible dismissal by a Special Litigation Committee. Direct claims proceed under ordinary pleading standards, are controlled by the plaintiff class or individuals, and any recovery goes directly to them.
How does Tooley affect common fiduciary-duty claims like dilution or unfair mergers?
Tooley provides the framework: analyze who was harmed and who benefits. Many classic overpayment or mismanagement claims are derivative because the corporation overpaid or lost value. Some stockholder-level injuries—such as lost merger consideration or vote-buying that affects stockholders' rights—are direct. Later cases applied and refined these distinctions; for example, Delaware once recognized certain dilution claims as "dual-nature" under Gentile v. Rossette, but in Brookfield Asset Management, Inc. v. Rosson (2021), the Delaware Supreme Court overruled Gentile and reaffirmed Tooley's primacy.
Did Tooley overrule prior Delaware cases?
Tooley did not overrule core fiduciary-duty doctrines, but it expressly disapproved and replaced the "special injury"/"duty owed" formulations that had crept into earlier decisions (e.g., Kramer and parts of Grimes) for distinguishing direct from derivative claims. It harmonized the law by focusing on harm and remedy rather than labels.
What remedy did the Tooley plaintiffs seek and why was it direct?
They sought damages equal to the time value (interest) lost due to the wrongful delay in paying the cash merger consideration. Because only stockholders, not the corporation, were entitled to that consideration, the harm and any recovery ran directly to stockholders, making the claim direct.